Alnylam Pharmaceuticals I... (ALNY)
NASDAQ: ALNY
· Real-Time Price · USD
447.72
-5.82 (-1.28%)
At close: Sep 05, 2025, 10:12 AM
Alnylam Pharmaceuticals Revenue
Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending June 30, 2025, Alnylam Pharmaceuticals generated $773.69M in revenue.
Revenue (ttm)
2.25B
Revenue Growth
22.97%
Price / Sales Ratio
13.36
Revenue / Employee
1.01M
Employees
2,230
Market Cap
58.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 2.25B | +22.97% |
| Dec 31, 2023 | 1.83B | +76.23% |
| Dec 31, 2022 | 1.04B | +22.88% |
| Dec 31, 2021 | 844.29M | +71.31% |
| Dec 31, 2020 | 492.85M | +124.28% |
| Dec 31, 2019 | 219.75M | +193.36% |
| Dec 31, 2018 | 74.91M | -16.69% |
| Dec 31, 2017 | 89.91M | +90.66% |
| Dec 31, 2016 | 47.16M | +14.75% |
| Dec 31, 2015 | 41.1M | -18.72% |
| Dec 31, 2014 | 50.56M | +7.20% |
| Dec 31, 2013 | 47.17M | -29.31% |
| Dec 31, 2012 | 66.72M | -19.37% |
| Dec 31, 2011 | 82.76M | -17.28% |
| Dec 31, 2010 | 100.04M | -0.49% |
| Dec 31, 2009 | 100.53M | +4.54% |
| Dec 31, 2008 | 96.16M | +88.94% |
| Dec 31, 2007 | 50.9M | +89.00% |
| Dec 31, 2006 | 26.93M | +371.13% |
| Dec 31, 2005 | 5.72M | +33.61% |
| Dec 31, 2004 | 4.28M | +2330.68% |
| Dec 31, 2003 | 176K | +Infinity% |
| Dec 31, 2002 | 0 | n/a |